From Prevention Matters Newsletter, Fall/Winter 2015 The National Comprehensive Cancer Network (NCCN) considers genetic testing of the BRCA1 and BRCA2 genes appropriate for any woman with a personal history of ovarian, fallopian tube, or primary peritoneal ...
Read More